用于类风湿性关节炎的脾酪氨酸激酶抑制剂：试验与磨难 - Suppr

Syk kinase inhibitors for rheumatoid arthritis: trials and tribulations.

作者信息

Boers Maarten

出版信息

Arthritis Rheum. 2011 Feb;63(2):329-30. doi: 10.1002/art.30109.

DOI:10.1002/art.30109

PMID:21279987

Abstract

摘要

相似文献

Syk kinase inhibitors for rheumatoid arthritis: trials and tribulations.

Arthritis Rheum. 2011 Feb;63(2):329-30. doi: 10.1002/art.30109.

Healing the Syk through kinase inhibitors.

N Engl J Med. 2010 Sep 30;363(14):1362-4. doi: 10.1056/NEJMe1006527. Epub 2010 Sep 22.

Spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis.

N Engl J Med. 2011 Jan 6;364(1):83; author reply 84. doi: 10.1056/NEJMc1012187.

The status of fostamatinib in the treatment of rheumatoid arthritis.

Expert Rev Clin Immunol. 2012 Sep;8(7):609-15. doi: 10.1586/eci.12.63.

Spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis.

N Engl J Med. 2011 Jan 6;364(1):83-4; author reply 84. doi: 10.1056/NEJMc1012187.

An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents.

Arthritis Rheum. 2011 Feb;63(2):337-45. doi: 10.1002/art.30114.

American College of Rheumatology hybrid measure for assessing efficacy of treatment in patients with refractory rheumatoid arthritis: comment on the article by Genovese et al.

Arthritis Rheum. 2011 Oct;63(10):3181-2; author reply 3182. doi: 10.1002/art.30544.

Promising new treatments for rheumatoid arthritis - the kinase inhibitors.

Bull NYU Hosp Jt Dis. 2011;69(3):233-7.

Therapy: Spleen tyrosine kinase inhibitors--novel therapies for RA?

Nat Rev Rheumatol. 2011 Mar;7(3):134-6. doi: 10.1038/nrrheum.2011.8. Epub 2011 Feb 8.

Fostamatinib, a Syk inhibitor prodrug for the treatment of inflammatory diseases.

IDrugs. 2009 Mar;12(3):174-85.

引用本文的文献

A new 3-arylbenzofuran derivative EIE-2 reestablishes Treg-dependent tolerance in rheumatoid arthritis by targeting on Syk induced mTOR and PKCθ imbalance.

Front Immunol. 2025 May 21;16:1524491. doi: 10.3389/fimmu.2025.1524491. eCollection 2025.

Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases.

Clin Exp Immunol. 2014 Apr;176(1):1-10. doi: 10.1111/cei.12248.

Cell-signaling therapy in rheumatoid arthritis.

Curr Rheumatol Rep. 2013 Oct;15(10):368. doi: 10.1007/s11926-013-0368-5.

Pathogenic intracellular and autoimmune mechanisms in urticaria and angioedema.

Clin Rev Allergy Immunol. 2013 Aug;45(1):47-62. doi: 10.1007/s12016-012-8326-y.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Syk kinase inhibitors for rheumatoid arthritis: trials and tribulations.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献